Lead Plaintiff Deadline is March 23, 2026 NEW YORK, Feb. 3, 2026 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP reminds purchasers of BellRing Brands, Inc. ("BellRing" or the "Company") (NYSE: BRBR) that a federal securities class action has been filed on behalf of investors who purchased BellRing between November 19, 2024 and August 4, 2025 (inclusive) (the "Class Period"). Investors have until March 23, 2026 to seek appointments as lead plaintiff.

image for news Shareholders who lost money in shares of BellRing Brands, Inc. (NYSE: BRBR) Should Contact Wolf Haldenstein Immediately

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026, at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and John Doherty, Executive Vice President and Chief Financial Officer.

image for news Butterfly Network to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

LEXINGTON, Ky., Feb. 03, 2026 (GLOBE NEWSWIRE) -- MiddleGround Capital (“MiddleGround”), an operationally focused private equity firm that makes control investments in North American and European headquartered middle-market B2B industrial and specialty distribution companies, today announced it has acquired Pi Innovo (“Pi Innovo”), from Dana Incorporated.

image for news MiddleGround Capital Completes Add-On for New Eagle Platform with Acquisition of Pi Innovo

Silver's Crash Is Getting Pretty Uncomfortable — Neutral

SLV   Investors Business Daily — February 03, 2026

Silver's rise was impressive. And now its fall — along with those of other precious metals' — is breathtaking.

image for news Silver's Crash Is Getting Pretty Uncomfortable

CUPERTINO, Calif., February 3, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aemetis, Inc.

image for news Aemetis India Subsidiary Begins Biodiesel Deliveries Under $24 Million Allocation from OMCs

Apple: Capital-Light AI Arbitrage Ignites iPhone Supercycle Alpha — Positive

AAPL   Seeking Alpha — February 03, 2026

Apple is upgraded to Strong Buy, driven by its Capital-Light AI Arbitrage strategy decoupling monetization from infrastructure intensity. AAPL's Q1-FY2026 saw record $143.8B revenue, 23% iPhone growth, and 38% Greater China sales, signaling a durable multi-year supercycle. Gross margin expansion to 48.2% under supply and memory cost pressures demonstrates robust pricing power and margin resilience.

image for news Apple: Capital-Light AI Arbitrage Ignites iPhone Supercycle Alpha

SOUTHLAKE, Texas and SHANGHAI, Feb. 3, 2026 /PRNewswire/ -- Sabre Corporation (NASDAQ: SABR), a leading global travel technology company, today announced a new agreement with Shanghai Fuxun Information Technology Co. Ltd. Through the deal, Sabre will add more than 100,000 domestic hotels across China to the extensive lodging content already available through SabreMosaic™ Travel Marketplace.

image for news Sabre unlocks access to 100,000 Chinese hotels, making SabreMosaic the only global travel marketplace to include domestic lodging content from China

YOKNEAM, Israel, Feb. 3, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer will host investor meetings at the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference in Snowbird, UT on Wednesday, February 11, 2026.

image for news InMode to Participate in the 13th Annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference

SAN DIEGO, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in Defense, National Security and Global Markets, today announced that Kratos has been awarded contracts valued in total at approximately $65 million to design, develop and deliver simulators and other solutions for warfighter training supporting operations and maintenance of key aircraft and other platforms. The Kratos-built training systems support a wide variety of knowledge sets across numerous aircraft, including the Army's CH47F Chinook and UH-60M Blackhawk helicopters, the Airforce's UH-1 Huey and more.

image for news Kratos Recently Received Aviation System and Related Warfighter Contract Awards with Total Potential Value of Approximately $65 Million

Powerfleet Announces Andrew Martin as New Chairman — Neutral

AIOT   PRNewsWire — February 03, 2026

WOODCLIFF LAKE, N.J., Feb. 3, 2026 /PRNewswire/ -- Powerfleet, Inc. (Nasdaq: AIOT), a global leader in the artificial intelligence of things (AIoT) SaaS mobile asset industry, today announced a board leadership transition.

image for news Powerfleet Announces Andrew Martin as New Chairman

New Power Module Enhances AI Data Center Power Density and Efficiency — Neutral

MCHP   GlobeNewsWire — February 03, 2026

CHANDLER, Ariz., Feb. 03, 2026 (GLOBE NEWSWIRE) -- The increasing AI and high-performance computing workloads demand power solutions that combine efficiency, reliability and scalability.

image for news New Power Module Enhances AI Data Center Power Density and Efficiency

LONDON, Feb. 3, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the launch of a video webinar, Intelligence Amplified in the Age of AI , an in‑depth session exploring how Clarivate is leveraging artificial intelligence to reshape research, innovation, and decision‑making across the scientific, academic, intellectual property, and life sciences ecosystems. Hosted by Matti Shem Tov, Chief Executive Officer of Clarivate, the webinar unveils how Clarivate is applying cutting-edge AI technology to amplify the value of its trusted intelligence, which is built on decades of investment in proprietary content, expert curation, and …

image for news Clarivate Webinar "Intelligence Amplified in the Age of AI" Highlights How Trusted, Proprietary Data Powers Next‑Generation Innovation

This is the first time MEAI, Clearmind's next-generation, non-hallucinogenic neuroplastogen, has been named in U.S. federal legislation Vancouver, Canada, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel neuroplastogen-derived therapeutics to solve major under-treated health problems, today welcomes the inclusion of its proprietary compound, MEAI (5-methoxy-2-aminoindane,or5-MeO-AI ), in newly introduced bipartisan legislation in the U.S. Congress. The Expanding Veterans' Access to Emerging Treatments Act of 2026 (H.R.

image for news Excellent Achievements for Clearmind's Proprietary MEAI that was Included in U.S. Congress' Emerging Therapies Bill to Expand Veteran Access to Innovative Treatments

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences — Neutral

CNTA   GlobeNewsWire — February 03, 2026

BOSTON and LONDON, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines for patients, today announced that members of its management team will participate in the following investor conferences: Event: Guggenheim Emerging Outlook: Biotech Summit Date: Thursday, February 12, 2026 Fireside Chat: 1:00 PM ET Event: TD Cowen 46th Annual Health Care Conference Date: Tuesday, March 3, 2026 Fireside Chat: 3:10 PM ET Event: Leerink Partners Global Healthcare Conference Date: Tuesday, March 10, 2026 Fireside Chat: 8:00 AM ET Event: Jefferies Biotech on the Beach Summit …

image for news Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

BOSTON, Feb. 3, 2026 /PRNewswire/ -- ZipBio, a biotechnology company pioneering AI-driven protein therapeutics, announced an exclusive license agreement with MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company. Under the agreement, MeiraGTx will receive exclusive rights to ZipBio's first-in-class therapies for Geographic Atrophy, targeting the complement pathway.

image for news ZipBio and MeiraGTx Enter into Exclusive License Agreement to Advance First-in-Class AAV Gene Therapy for Geographic Atrophy

New Brand Reflects the Business as the Global Standard for Automotive Intelligence; Will Be Used Upon Separation as Standalone Public Company NEW YORK, Feb. 3, 2026 /PRNewswire/ -- S&P Global (NYSE: SPGI) today announced Mobility Global, Inc ("Mobility Global") will be the corporate name for the S&P Global Mobility business upon completion of its planned separation from S&P Global into a standalone public company. The Mobility Global name reflects its leadership in providing critical intelligence across the vehicle lifecycle to suppliers, OEMs, dealers, and consumers worldwide.

image for news S&P Global Introduces New Brand Identity for Mobility Division as "Mobility Global"

Synchrony to Participate in the 2026 UBS Financial Services Conference — Neutral

SYF   PRNewsWire — February 03, 2026

STAMFORD, Conn., Feb. 3, 2026 /PRNewswire/ -- Synchrony (NYSE: SYF) Chief Financial Officer, Brian J.

image for news Synchrony to Participate in the 2026 UBS Financial Services Conference

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a mid-cap growth and value biotech company, today announced that a total of 114,869 equity awards, consisting of 107,742 restricted stock units (“RSUs”) and up to 7,127 performance stock units (“PSUs”), will be granted to 52 recently hired individuals, in each case as an inducement material to their acceptance of employment wi.

image for news Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced the appointments of Daven Mody, Pharm.D., as Senior Vice President of Regulatory and Quality and Bruno Gagnon, B.Pharm., M.Sc., as Senior Vice President, Clinical Development Operations. “We are delighted to welcome both Daven and Brun.

image for news Spruce Biosciences Adds Regulatory and Clinical Development Expertise to Leadership Team

WALTHAM, Mass.--(BUSINESS WIRE)--Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, announced today that Louisiana's East Baton Rouge Parish Schools is expanding its partnership with the company. The district, which initially deployed Evolv Express® weapons detection system last year, has added systems to eight more schools in the region. This expansion, in partnership with Alliance Technolo.

image for news East Baton Rouge Parish Schools Triples its Evolv Express Gen2 Fleet, Strengthening Districtwide Security